KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Precigen (PGEN) over the last 13 years, with Q2 2025 value amounting to $1.3 million.

  • Precigen's Gains from Investment Securities changed N/A to $1.3 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 17750000.0%. This contributed to the annual value of -$2000.0 for FY2023, which is 9813.08% up from last year.
  • Latest data reveals that Precigen reported Gains from Investment Securities of $1.3 million as of Q2 2025.
  • Over the past 5 years, Precigen's Gains from Investment Securities peaked at $1.3 million during Q2 2025, and registered a low of -$150000.0 during Q4 2021.
  • Its 4-year average for Gains from Investment Securities is $168666.7, with a median of -$1000.0 in 2021.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 9653.9% in 2021, then soared by 15000.0% in 2023.
  • Over the past 4 years, Precigen's Gains from Investment Securities (Quarter) stood at -$150000.0 in 2021, then skyrocketed by 98.67% to -$2000.0 in 2022, then skyrocketed by 150.0% to $1000.0 in 2023, then soared by 130100.0% to $1.3 million in 2025.
  • Its Gains from Investment Securities was $1.3 million in Q2 2025, compared to $474000.0 in Q1 2025 and $1000.0 in Q4 2023.